Jenoptik’s BioPhotonics Group garners four new development orders
Jenoptik Light and Optics’ BioPhotonics group (Jupiter, FL) has recently won a number of new development orders in North America. These new projects demonstrate the company’s precision optical system design capabilities and its commitment to advancing medical device innovations.
The first order is for the design of the camera system for a next-generation fiber-optic medical device to be used in a robotic surgical instrument. The client is a worldwide supplier of medical equipment and selected Jenoptik for its expertise in microoptics, injection-molded optics, and imaging systems.
The second development project is for the design of multiple subassemblies for a Tier 1 eye care company’s next-generation ophthalmology surgery system. This customer leverages Jenoptik’s proficiency in illumination systems, fiber optics, imaging systems, microoptics, and lasers to provide key optical subsystems for their product.
For the third program, Jenoptik is teaming with a major worldwide supplier of medical laboratory equipment to supply a next-generation automated microscope for inline cellular analysis. The customer approached Jenoptik for its capabilities in microscopy, illumination systems, and imaging systems.
The fourth project is the continuation of a long-standing partnership with a medical diagnostics company specializing in real-time point-of-care (POC) serology tests. This customer came to Jenoptik because of its track record in solving complex optical system engineering problems. As a partner, the company helped to design and build a next-generation POC serology test system that is U.S. FDA-approved for use in COVID-19 diagnosis.
The incremental revenue after these engineering programs are completed and ramp into serial production is expected to exceed over $10.8 million annually, which will accelerate the growth of the BioPhotonics business in North America and worldwide.